Author

Sima Bhatt

Institution: Disc Medicine, Inc. (United States)

Observed institution: Disc Medicine, Inc. (United States)

OpenAlex ID: A5137167172

RALLY-MF: Initial efficacy of a phase 2 study of DISC-0974, an anti-hemojuvelin antibody, to treat anemia in myelofibrosis.

2026 · Naseema Gangat, Ayalew Tefferi, et al. · Journal of Clinical Oncology · 2

ORAL ABSTRACT: MPN-120: RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

2026 · Naseema Gangat, Ayalew Tefferi, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-809: Characterizing the Humanistic Burden of Anemia Associated With Myelofibrosis Through Patient-Reported Outcomes: Findings From a Systematic Literature Review

2026 · Lindsay AM Rein, Bhagyashree Oak, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-120: RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

2026 · Naseema Gangat, Ayalew Tefferi, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-809: Characterizing the Humanistic Burden of Anemia Associated With Myelofibrosis Through Patient-Reported Outcomes: Findings From a Systematic Literature Review

2026 · Lindsay AM Rein, Bhagyashree Oak, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-120: RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

2026 · Naseema Gangat, Ayalew Tefferi, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 6

Citation count: 2

H-index: 1

I10-index: